272 related articles for article (PubMed ID: 31735312)
1. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
[TBL] [Abstract][Full Text] [Related]
2. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Cardiol Clin; 2022 May; 40(2):161-169. PubMed ID: 35465890
[TBL] [Abstract][Full Text] [Related]
3. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Microbiome in Heart Failure.
Kitai T; Kirsop J; Tang WH
Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
[TBL] [Abstract][Full Text] [Related]
5. Association of gut-related metabolites with outcome in acute heart failure.
Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
[TBL] [Abstract][Full Text] [Related]
6. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
Zhang J; Wang L; Cai J; Lei A; Liu C; Lin R; Jia L; Fu Y
J Neuroimmunol; 2021 May; 354():577526. PubMed ID: 33647820
[TBL] [Abstract][Full Text] [Related]
7. Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
Emoto T; Hayashi T; Tabata T; Yamashita T; Watanabe H; Takahashi T; Gotoh Y; Kami K; Yoshida N; Saito Y; Tanaka H; Matsumoto K; Hayashi T; Yamada T; Hirata KI
Int J Cardiol; 2021 Sep; 338():138-142. PubMed ID: 34102245
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
10. Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
Nowiński A; Ufnal M
Nutrition; 2018 Feb; 46():7-12. PubMed ID: 29290360
[TBL] [Abstract][Full Text] [Related]
11. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
Nagatomo Y; Tang WH
J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
[TBL] [Abstract][Full Text] [Related]
12. Trimethylamine oxide: a potential target for heart failure therapy.
Lv S; Wang Y; Zhang W; Shang H
Heart; 2022 May; 108(12):917-922. PubMed ID: 34611047
[TBL] [Abstract][Full Text] [Related]
13. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure.
Anderson KM; Ferranti EP; Alagha EC; Mykityshyn E; French CE; Reilly CM
Heart Fail Rev; 2022 Nov; 27(6):2223-2249. PubMed ID: 35726110
[TBL] [Abstract][Full Text] [Related]
14. Levels of Trimethylamine N-Oxide Remain Elevated Long Term After Left Ventricular Assist Device and Heart Transplantation and Are Independent From Measures of Inflammation and Gut Dysbiosis.
Yuzefpolskaya M; Bohn B; Javaid A; Mondellini GM; Braghieri L; Pinsino A; Onat D; Cagliostro B; Kim A; Takeda K; Naka Y; Farr M; Sayer GT; Uriel N; Nandakumar R; Mohan S; Colombo PC; Demmer RT
Circ Heart Fail; 2021 Jun; 14(6):e007909. PubMed ID: 34129361
[TBL] [Abstract][Full Text] [Related]
15. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424
[TBL] [Abstract][Full Text] [Related]
16. TMAO: how gut microbiota contributes to heart failure.
Zhang Y; Wang Y; Ke B; Du J
Transl Res; 2021 Feb; 228():109-125. PubMed ID: 32841736
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
[TBL] [Abstract][Full Text] [Related]
18. Trimethylamine N-oxide in cardiovascular disease.
Konieczny RA; Kuliczkowski W
Adv Clin Exp Med; 2022 Aug; 31(8):913-925. PubMed ID: 35438848
[TBL] [Abstract][Full Text] [Related]
19. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
[TBL] [Abstract][Full Text] [Related]
20. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
